Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Headache Disorders Market?

In recent times, the market size for headache disorders has seen robust growth. The forecast suggests a growth from $4.64 billion in 2024 to $4.93 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. The substantial growth during the historic period is due to factors such as limited treatment alternatives, increased awareness, higher occurrence rates of headaches, development in healthcare infrastructure, changes in lifestyle, and elevated stress levels.

The market size for headache disorders is projected to experience substantial expansion in the coming years, increasing to $6.83 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 8.5%. The predicted growth within this period can be credited to the rise of digital health solutions, tailored medical treatments, heightened investments in research and development, the worldwide aging population, and a surge in research on neuroinflammation. The forecast period is set to witness significant trends such as advancements in treatment technology, personalized medicine, an amplified emphasis on preventive therapies, an enlarging repertoire of innovative therapies, and the increasing application of non-pharmaceutical methods.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9452&type=smp

Which Factor Is Shaping The Future Of The Headache Disorders Market?

The headache disorders market is set to experience growth, driven by the rising occurence of migraines. Migraines, a specific type of headache, manifest as recurring bouts of moderate to extreme pain, often throbbing or pulsating, and typically concentrated on one side of the head. These headache disorders may lead to neurological disorders, resulting in debilitating pain, fatigue, and nausea, all of which may contribute to the onset of migraines. For instance, a study published in the UK-based, peer-reviewed Journal of Headache and Pain in April 2022 reported that 52.0% of the surveyed population had an active headache disorder of some kind. Within those numbers, 44.4% were male and 57.8% were female. Furthermore, migraines affected 14.0% of the population, including 8.6% males and 17.0% females. Meanwhile, tension-type headaches (TTH) were found in 26.0% of the population, affecting 23.4% males and 27.1% females. As such, the growing occurrence of migraines is fuelling demand within the headache disorders market.

What Is The Segment-Wise Breakdown Of The Headache Disorders Market?

The headache disorders market covered in this report is segmented –

1) By Type: Migraine, Tension-Type Headache, Cluster Headache, Medication-Overuse Headache, Other Types

2) By Treatment: Medication, Heat Therapy, Diet Changes, Acupuncture, Oxygen Therapy

3) By Diagnosis: Complete Blood Count, Skull X-Rays, Sinus X-Rays, CT Scan, Magnetic Resonance Imaging (MRI)

4) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Migraine: Chronic Migraine, Episodic Migraine, Migraine With Aura, Migraine Without Aura

2) By Tension-Type Headache: Episodic Tension-Type Headache, Chronic Tension-Type Headache

3) By Cluster Headache: Chronic Cluster Headache, Episodic Cluster Headache

4) By Medication-Overuse Headache: Analgesic-Overuse Headache, Caffeine-Withdrawal Headache

5) By Other Types: Sinus Headache, Hormonal Headache, Thunderclap Headache, Other Primary And Secondary Headaches

Which Trends Are Redefining The Future Landscape Of The Headache Disorders Industry?

Leading companies within the headache disorder market are concentrating on the creation of innovative products, such as migraine tablets, in order to expand treatment possibilities and boost patient results. Migraine tablets, which are aimed specifically at curtailing or stopping migraine attacks by focusing on certain migraine symptom pathways such as pain and inflammation, are making a significant impact. In January 2024, Akums Drugs & Pharmaceuticals, a pharmaceutical producer based in India, debuted the Lasmiditan Tablet. This tablet is a generic version of Eli Lilly’s REYVOW and targets acute migraine treatment. Lasmiditan, approved by the Drug Controller General of India (DCGI) as well as the US Food and Drug Administration (USFDA), works by binding to the 5-HT1F serotonin receptor, disrupting pain communications and reducing nerve inflammation. The suggested dosage varies between 50 mg and 100 mg, with a limit of one dose every 24 hours.

Which Companies Hold The Largest Market Share In The Headache Disorders Sector?

Major companies operating in the headache disorders market include Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd, Emcure Pharmaceuticals Limited, Endo International plc, WorldMeds LLC, AstraZeneca plc, Bausch & Lomb Incorporated, Nichi-Iko Pharmaceutical Co, Upsher-Smith Laboratories LLC, Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH., Gilead Sciences Inc., Amgen Inc., Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eisai Co. Ltd., Impax Laboratories LLC, Lannett Company Inc., Lupin Pharmaceuticals Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/headache-disorders-global-market-report

How Does Regional Performance Compare Across The Headache Disorders Industry?

North America was the largest region in the headache disorders market in 2024. The regions covered in the headache disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9452&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model